Wedbush Cuts Earnings Estimates for Dianthus Therapeutics
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Investment analysts at Wedbush decreased their Q1 2025 earnings per share estimates for Dianthus Therapeutics in a research report issued on Wednesday, March 12th. Wedbush analyst L. Chico now expects that the company will post earnings per share of ($0.74) for the quarter, down from their prior […]
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Investment analysts at Wedbush decreased their Q1 2025 earnings per share estimates for Dianthus Therapeutics in a research report issued on Wednesday, March 12th. Wedbush analyst L. Chico now expects that the company will post earnings per share of ($0.74) for the quarter, down from their prior […]
-logo.png?v=20230920074015&w=240&h=240&zc=2){kind=logo}
